OPKO Health CEO Frost on 4Kscore Test for Prostate Cancer

The video discusses OPKO's 4K Score, a cost-saving prostate cancer test, and its potential acceptance in a changing healthcare landscape. It covers OPKO's financial strategy, emphasizing low debt and selective acquisitions. The impact of political changes on the biotech industry, including regulatory hurdles and pricing pressures, is also explored.

In what ways could political developments affect the biotech industry?

What are the implications of regulatory hurdles in the pharmaceutical business?